Arthur J. Benvenuto
Directeur Général chez Micell Technologies, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Daniel Estay | M | - |
Micell Technologies, Inc.
 Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Kenneth Langone | M | 88 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Robert Langer | M | 74 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Michael Stansky | M | 64 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| Dennis J. Donohoe | M | 72 |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
| John W. Lowry | M | - |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| David A. Dresner | M | - |
Micell Technologies, Inc.
Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 7 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Arthur J. Benvenuto
- Réseau Personnel
